CStone Pharmaceuticals

NEW
STU:PH4 (China)  
€ 0.56 +0.063 (+12.7%) Aug 7
At Loss
P/B:
12.81
Market Cap:
€ 926.65M ($ 1.07B)
Enterprise V:
€ 853.35M ($ 986.58M)
Volume:
0
Avg Vol (2M):
16.77K
Trade In:

CStone Pharmaceuticals (STU:PH4) Dividend

CStone Pharmaceuticals (STU:PH4) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -7.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:PH4 Dividend

Does CStone Pharmaceuticals (STU:PH4) pay a dividend?

CStone Pharmaceuticals (STU:PH4) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't CStone Pharmaceuticals pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. CStone Pharmaceuticals has returned capital to shareholders via buybacks at a rate of -7.2% over the past 3 years.

What are dividend-paying alternatives to CStone Pharmaceuticals?

For dividend-paying alternatives in CStone Pharmaceuticals's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.